All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
BIL / SPDR Series Trust - SPDR Bloomberg 1-3 Month T-Bill ETF
|
|
|
|
|
|
|
|
ANF / Abercrombie & Fitch Co.
|
|
|
|
|
|
|
|
PRDS / Pardes Biosciences Inc
|
|
|
|
|
|
|
|
GRAY / Graybug Vision Inc
|
|
|
|
|
|
|
|
ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
US29079J2024 / Embark Technology Inc
|
|
|
|
|
|
|
|
PASG / Passage Bio, Inc.
|
|
|
|
|
|
|
|
ORMP / Oramed Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LSTA / Lisata Therapeutics, Inc.
|
|
|
|
|
|
|
|
SPRB / Spruce Biosciences, Inc.
|
|
|
|
|
|
|
|
ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
|
|
|
|
|
|
STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
SESN / Sesen Bio Inc.
|
|
|
|
|
|
|
|
TLYS / Tilly's, Inc.
|
|
|
|
|
|
|
|
JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
RELL / Richardson Electronics, Ltd.
|
|
|
|
|
|
|
|
ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
CARM / Carisma Therapeutics, Inc.
|
|
|
|
|
|
|
|
TALS / Talaris Therapeutics Inc
|
|
|
|
|
|
|
|
RVP / Retractable Technologies, Inc.
|
|
|
|
|
|
|
|
SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
SGOV / iShares Trust - iShares 0-3 Month Treasury Bond ETF
|
|
|
|
|
|
|
|
ELYM / Eliem Therapeutics, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
FBRX / Forte Biosciences, Inc.
|
|
|
|
|
|
|
|
CYTT / Cyteir Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASTC / Astrotech Corporation
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|